Citigroup’s Twist Bioscience TWST Stock Holding History

Citigroup’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-14,600	Closed	-$501K	–	5786
2024 Q1	$501K	Buy	+14,600	New	+$527K	﹤0.01%	3572

Other funds holding TWST

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citigroup's TWST Position: Q1 2026 in Review

Citigroup increased its Twist Bioscience (TWST) stake by 15% in Q1 2026, buying an estimated $2.65M and bringing the position to 460,287 shares worth $21.9M. The position accounts for 0.01% of the portfolio, ranked #1012.

Citigroup first reported a position in TWST in Q4 2018 and has held it in 30 quarters since. 279 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

Citigroup held 460,287 shares of Twist Bioscience worth $21.9M as of Q1 2026.
Citigroup bought 59,005 Twist Bioscience shares in Q1 2026, an estimated $2.65M.
Twist Bioscience made up 0.01% of Citigroup's portfolio in Q1 2026, its #1012 holding.
Citigroup first reported a position in Twist Bioscience in Q4 2018 and has held it in 30 quarters since.
279 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.